337 related articles for article (PubMed ID: 24686433)
1. Recall processes for biliary cytology in primary sclerosing cholangitis.
Eaton JE; Gossard AA; Talwalkar JA
Curr Opin Gastroenterol; 2014 May; 30(3):287-94. PubMed ID: 24686433
[TBL] [Abstract][Full Text] [Related]
2. Screening and diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis.
Jesudian AB; Jacobson IM
Rev Gastroenterol Disord; 2009; 9(2):E41-7. PubMed ID: 19668124
[TBL] [Abstract][Full Text] [Related]
3. Polysomy and p16 deletion by fluorescence in situ hybridization in the diagnosis of indeterminate biliary strictures.
Gonda TA; Glick MP; Sethi A; Poneros JM; Palmas W; Iqbal S; Gonzalez S; Nandula SV; Emond JC; Brown RS; Murty VV; Stevens PD
Gastrointest Endosc; 2012 Jan; 75(1):74-9. PubMed ID: 22100297
[TBL] [Abstract][Full Text] [Related]
4. Primary sclerosing cholangitis patients with serial polysomy fluorescence in situ hybridization results are at increased risk of cholangiocarcinoma.
Barr Fritcher EG; Kipp BR; Voss JS; Clayton AC; Lindor KD; Halling KC; Gores GJ
Am J Gastroenterol; 2011 Nov; 106(11):2023-8. PubMed ID: 21844920
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic performance of a stepwise cytological algorithm for biliary malignancy in primary sclerosing cholangitis.
von Seth E; Ouchterlony H; Dobra K; Hjerpe A; Arnelo U; Haas S; Bergquist A
Liver Int; 2019 Feb; 39(2):382-388. PubMed ID: 30507030
[TBL] [Abstract][Full Text] [Related]
6. The Detection of Cholangiocarcinoma in Primary Sclerosing Cholangitis Patients: Single Center Experience.
Kuzu UB; Ödemiş B; Suna N; Yıldız H; Parlak E; Dişibeyaz S; Torun S; Akpınar MY; Coşkun O; Turhan N; Yüksel M; Kayaçetin E
J Gastrointest Cancer; 2016 Mar; 47(1):8-14. PubMed ID: 26537791
[TBL] [Abstract][Full Text] [Related]
7. Screening primary sclerosing cholangitis and biliary dysplasia with endoscopic retrograde cholangiography and brush cytology: risk factors for biliary neoplasia.
Boyd S; Tenca A; Jokelainen K; Mustonen H; Krogerus L; Arola J; Färkkilä MA
Endoscopy; 2016 May; 48(5):432-9. PubMed ID: 26808393
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis, diagnosis and treatment of premalignant and malignant stages of cholangiocarcinoma in primary sclerosing cholangitis.
Grimsrud MM; Folseraas T
Liver Int; 2019 Dec; 39(12):2230-2237. PubMed ID: 31216595
[TBL] [Abstract][Full Text] [Related]
9. Clinical implications of serial versus isolated biliary fluorescence in situ hybridization (FISH) polysomy in primary sclerosing cholangitis.
Quinn KP; Tabibian JH; Lindor KD
Scand J Gastroenterol; 2017 Apr; 52(4):377-381. PubMed ID: 27908204
[TBL] [Abstract][Full Text] [Related]
10. Primary sclerosing cholangitis and cholangiocarcinoma.
Lazaridis KN; Gores GJ
Semin Liver Dis; 2006 Feb; 26(1):42-51. PubMed ID: 16496232
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes of positive fluorescence in situ hybridization tests in primary sclerosing cholangitis.
Bangarulingam SY; Bjornsson E; Enders F; Barr Fritcher EG; Gores G; Halling KC; Lindor KD
Hepatology; 2010 Jan; 51(1):174-80. PubMed ID: 19877179
[TBL] [Abstract][Full Text] [Related]
12. Biliary multifocal chromosomal polysomy and cholangiocarcinoma in primary sclerosing cholangitis.
Eaton JE; Barr Fritcher EG; Gores GJ; Atkinson EJ; Tabibian JH; Topazian MD; Gossard AA; Halling KC; Kipp BR; Lazaridis KN
Am J Gastroenterol; 2015 Feb; 110(2):299-309. PubMed ID: 25623660
[TBL] [Abstract][Full Text] [Related]
13. Risk of cholangiocarcinoma in patients with primary sclerosing cholangitis: diagnosis and surveillance.
Ehlken H; Zenouzi R; Schramm C
Curr Opin Gastroenterol; 2017 Mar; 33(2):78-84. PubMed ID: 28146445
[TBL] [Abstract][Full Text] [Related]
14. Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study.
Chalasani N; Baluyut A; Ismail A; Zaman A; Sood G; Ghalib R; McCashland TM; Reddy KR; Zervos X; Anbari MA; Hoen H
Hepatology; 2000 Jan; 31(1):7-11. PubMed ID: 10613720
[TBL] [Abstract][Full Text] [Related]
15. Cost utility of ERCP-based modalities for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis.
Njei B; McCarty TR; Varadarajulu S; Navaneethan U
Gastrointest Endosc; 2017 Apr; 85(4):773-781.e10. PubMed ID: 27590963
[TBL] [Abstract][Full Text] [Related]
16. Characteristic Features of Cholangiocarcinoma Complicating Primary Sclerosing Cholangitis.
Ishii Y; Sasaki T; Serikawa M; Kobayashi K; Kamigaki M; Minami T; Okazaki A; Yukutake M; Ishigaki T; Kosaka K; Mouri T; Yoshimi S; Chayama K
Hepatogastroenterology; 2014 May; 61(131):567-73. PubMed ID: 26176037
[TBL] [Abstract][Full Text] [Related]
17. Biliary dysplasia in primary sclerosing cholangitis harbors cytogenetic abnormalities similar to cholangiocarcinoma.
Kerr SE; Barr Fritcher EG; Campion MB; Voss JS; Kipp BR; Halling KC; Lewis JT
Hum Pathol; 2014 Sep; 45(9):1797-804. PubMed ID: 25027853
[TBL] [Abstract][Full Text] [Related]
18. Trends in pre-liver transplant screening for cholangiocarcinoma among patients with primary sclerosing cholangitis.
Trilianos P; Selaru F; Li Z; Gurakar A
Digestion; 2014; 89(2):165-73. PubMed ID: 24577150
[TBL] [Abstract][Full Text] [Related]
19. Hepatobiliary and extra-hepatic malignancies in primary sclerosing cholangitis.
Bergquist A; Broomé U
Best Pract Res Clin Gastroenterol; 2001 Aug; 15(4):643-56. PubMed ID: 11492973
[TBL] [Abstract][Full Text] [Related]
20. [Cholangiocarcinoma in primary sclerosing cholangitis: "chronicle of a death foretold"?].
Margalit M; Elinav H; Goldin E; Ilan Y
Harefuah; 2003 Jun; 142(6):421-5, 486. PubMed ID: 12858825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]